| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3901441 | Urology | 2012 | 6 Pages |
Abstract
VEGF could be a valuable addition to voided urine sample analysis for the detection of BCa. Larger, prospective studies are needed to determine the clinical utility of urinary VEGF and angiogenin as biomarkers in the noninvasive evaluation of patients with BCa.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Virginia Urquidi, Steve Goodison, Jeongsoon Kim, Myron Chang, Yunfeng Dai, Charles J. Rosser,